Medical Cannabis Patient Center to Open in Duluth/Hermantown

The new Green Goods medical cannabis dispensary will provide certified patients with best-in-class plant-based medicines and patient service

MINNEAPOLIS – November 18, 2020 – Vireo Health of Minnesota, LLC (“Vireo” or “the Company”), a subsidiary of Vireo Health International, Inc. (CNSX: VREO, OTCQX: VREOF), today announced the official opening of a new medical cannabis patient center in Duluth/Hermantown. The new location, called Green Goods, is the first of four new cannabis patient centers the Company expects to open in Minnesota by the end of 2020.

Green Goods Duluth/Hermantown is located at 4900 Miller Trunk Highway, Hermantown, MN 55811 and will offer medical cannabis in a variety of consumption formats familiar to most patients, including soft gels capsules, oral solutions, tablets, and concentrated cannabis oils. Green Goods will also feature a ‘knowledge bar’ for patients seeking expert information and full time, onsite pharmacists to help guide patients through their medical cannabis journey.

A Minnesota-based company founded in 2014 by Minneapolis emergency physician Dr. Kyle Kingsley, Vireo is committed to helping Minnesotans who qualify for medical cannabis to better understand and gain access to safe, effective cannabis-based products.

“As a board-certified physician and lifelong Minnesotan, it is an honor to open the first medical cannabis patient center in the Duluth area,” said Chairman and Chief Executive Officer, Dr. Kyle Kingsley. “As the fourth-largest city in Minnesota, Duluth is severely underserved for medical cannabis patients, who currently have to drive hours to access this life-changing medicine. Green Goods will work to serve and educate both patients and the local communities on the positive impact of medical cannabis.”

Green Goods locations are designed to create an inviting atmosphere that provides personalized service and wellness programs for patients. The locations will also be used for community engagement events, charitable giving programs, and educational outreach efforts. The Company’s existing cannabis patient centers in Minneapolis, Bloomington, Rochester, and Moorhead were recently renovated to create a relaxing and engaging environment that helps streamline the process of purchasing medical cannabis products in order to help serve more patients in a timely fashion.

Vireo Health of Minnesota expects to open three more Green Goods locations in Minnesota this year, the new cannabis patient centers will be in Blaine, Burnsville, and Woodbury. To learn more about Vireo Health of Minnesota and Green Goods retail locations, please visit www.minnesotamedicalsolutions.com.

About Vireo Health International, Inc.

Vireo Health International, Inc. (“Vireo” or the “Company”) is a Minnesota-based, physician-led cannabis company focused on bringing the best of technology, science, and engineering to the cannabis industry. Vireo manufactures proprietary, branded cannabis products in environmentally-friendly, state-of-the-art greenhouses and distributes its products through its growing network of Green GoodsTM retail dispensaries and through hundreds of third-party dispensaries in seven states. Vireo’s team of more than 400 employees, led by scientists, engineers, and cultivation experts, is focused on efficiency and the creation of best-in-class products, while driving scientific innovation within the cannabis industry and developing meaningful intellectual property. Today, Vireo is licensed to grow and/or process cannabis in 7 markets. The Company is operational in 6 of those 7 markets – including the core markets of Minnesota, New York, Arizona, Maryland, and New Mexico. The Company holds 32 total retail dispensary licenses, of which 13 are currently open for business.  For more information about Vireo Health, please visit www.vireohealth.com.

Media Inquiries

Albe Zakes

Vice President, Corporate Communications

albezakes@vireohealth.com

(267) 221-4800

Investor Inquiries

Sam Gibbons

Vice President, Investor Relations

samgibbons@vireohealth.com

(612) 314-8995

Minnesota Medical Solutions’ Cannabis Patient Centers Rebranded to Green Goods

MinnMed will become Vireo Health of Minnesota as the Company rebrands its retail locations to help better serve Minnesota’s medical cannabis patients

MINNEAPOLISSept. 15, 2020 /PRNewswire/ — Vireo Health International Inc., (“Vireo” or the “Company”) (CNSX: VREO; OTCQX: VREOF), a leading physician-founded, science-focused multi-state cannabis company, today announced that Minnesota Medical Solutions (MinnMed), the company’s subsidiary in Minnesota, has changed its name to Vireo Health of Minnesota and its cannabis patient centers are in the process of being renovated and rebranded. The retail locations will now be called Green Goods.

The Company’s existing cannabis patient centers in MinneapolisBloomingtonRochester, and Moorhead are being improved and renovated to help create a best-in-class patient experience. The renovations will create a relaxed and engaging environment that helps streamline the process of purchasing medical cannabis products to help serve more patients in a timely fashion. The rebranding and exterior renovations are nearly complete and interior updates are ongoing at all existing locations.

Vireo Health of Minnesota expects to open two new locations in Blaine and Hermantown under the Green Goods brand by November of this year, with an additional two locations in Burnsville and Woodbury expected to be open by the end of 2020.

“The Green Goods brand is the next evolution of Vireo’s continued commitment to providing patients with best-in-class medical cannabis products and customer experiences,” said Kyle Kingsley, MD, CEO and Founder of Vireo Health. “The new renovated locations will both allow us to better serve patients and transform how we interact with local communities and employees.”

Building on the Company’s commitment to putting patients first, Green Goods locations will offer an inviting atmosphere that provides personalized service and wellness programs. Each location will also feature a ‘knowledge bar’ for patients seeking expert information and on-site pharmacists to help guide patients through their medical cannabis journey. The renovated shops will also be used for community engagement events, charitable giving programs, and educational outreach efforts.

Green Goods will continue to provide the same quality medical cannabis products and expert service to patients. Products will be repackaged under the Vireo Health brand, but nothing else about the products offered will change – the formulas, prices, and application formats will remain the same. Each Green Goods location will offer Vireo Health of Minnesota’s full range of pharmaceutical-grade cannabis products.

To learn more about Vireo Health of Minnesota and Green Goods retail locations, please visit www.minnmed.com.

About Vireo Health International, Inc.

Vireo Health International, Inc. (“Vireo” or the “Company”) is a physician-led cannabis company focused on bringing the best of technology, science, and engineering to the cannabis industry. Vireo manufactures proprietary, branded cannabis products in environmentally-friendly, state-of-the-art greenhouses and distributes its products through its growing network of Green GoodsTM retail dispensaries and through hundreds of third-party dispensaries in seven states. Vireo’s team of more than 400 employees, led by scientists, engineers, and cultivation experts, is focused on efficiency and the creation of best-in-class products, while driving scientific innovation within the cannabis industry and developing meaningful intellectual property. Today, Vireo is licensed to grow and/or process cannabis in 9 markets. The Company is operational in 7 of those 9 markets – including the core markets of Arizona, Maryland, MinnesotaNew Mexico, and New York. The Company holds 32 total retail dispensary licenses, of which 13 are currently open for business.  For more information about Vireo Health, please visit www.vireohealth.com.

Contact Information

Media Inquiries
Albe Zakes
Vice President, Corporate Communications 
albezakes@vireohealth.com    
(267) 221-4800

Investor Inquiries
Sam Gibbons
Vice President, Investor Relations
samgibbons@vireohealth.com 
(612) 314-8995

SOURCE Vireo Health International, Inc.

Minnesota Medical Solutions Announces Agreement with United Food and Commercial Workers Union Local 1189

Minnesota Medical Solutions Announces Agreement with United Food and Commercial Workers Union Local 1189

MINNEAPOLIS – Minnesota Medical Solutions, a Vireo Health company, today announced the unanimous ratification of a new three-year agreement by their union workforce, UFCW Local 1189.

“This innovative agreement between MinnMed and UFCW aligns business and labor interests and ensures that our employees benefit as our Company becomes more successful,” said Dr. Kyle Kingsley, CEO of Vireo Health. “The agreement underscores our commitment to providing employees with fair wages and great benefits, and will help us recruit and retain the best talent. With that talent, we can provide patients with high-quality products and compassionate care, and also build a profitable business. It is incumbent upon us to lay an economic foundation that will provide employees with the wages and benefits their families deserve and invest in ways that help local economies across Minnesota prosper.”

“We were really pleased to be able to recommend this offer to our members,” said Jennifer Christensen, President of Local 1189. “It is a fair settlement that will ensure that the company is able to recruit and retain exceptional workers. This is important not just for our members, but for the medical cannabis patients in Minnesota.”

The agreement included an extension of the employer’s commitment to cover all costs associated with health insurance through 2017. After that, full-time employees will begin to contribute $5 per week toward the union’s Health and Welfare Plan.

“What is really important is the employer’s commitment to full-time living wage union jobs,” added Christensen. “Part-time jobs do exist but as business expands and hours become available those jobs are transformed into full-time. Minnesota Medical Solutions is leading the way nationally, and it shows in the quality of products and services that our members provide for the people of Minnesota.”

Additionally, there were changes to the paid time off (PTO) policy, an increase in holidays and changes to the mileage and travel time reimbursement system. There will also be an additional position in the bargaining unit for the union.

Vireo Health also has an agreement with its union workforce in New York, being the first medical cannabis company to ratify a labor contract in the Empire State.

-30-

About Vireo Health: Vireo Health, LLC is a physician-led company dedicated to alleviating pain and suffering by providing patients with high-quality cannabis-based products and compassionate patient care. Vireo is the parent company of two wholly-owned subsidiaries licensed to operate in New York and Minnesota – Vireo Health of New York and Minnesota Medical Solutions. The Company plans to expand into more states and recently received preliminary approval to cultivate and manufacture medical cannabis in Maryland. For more information, visit www.vireohealth.com.

MinnMed Announces Price Reductions to make Medical Cannabis More Accessible to Patients

MinnMed Announces Price Reductions to make Medical Cannabis More Accessible to Patients
Special discount program launched for active military and veterans

Minneapolis, MN – Minnesota Medical Solutions (“MinnMed”), one of the two companies licensed by the state to cultivate, manufacture and dispense medical cannabis, has announced unprecedented price reductions that will make medical cannabis more affordable and accessible to Minnesota patients.

As part of its commitment to improve patient access to Minnesotans, MinnMed has reduced the prices of more than two-dozen medical cannabis products, some by more than 50%.

“My top priority as a physician is to ensure that patients have access to the medicine they need,” said Dr. Kyle Kingsley, Chief Executive Officer of Minnesota Medical Solutions and Vireo Health. “It pains me any time I learn of an individual who qualifies for medical cannabis but cannot afford to purchase these medications. The impetus for today’s decision to reduce prices is to improve patient access by making cannabis medicines significantly more affordable to Minnesotans struggling with life-threatening and debilitating conditions.”

Prices have been reduced across the Vireo Spectrum™ – including THC dominant, CBD dominant and balanced medications – so that all patients, regardless of their qualifying medical condition, could benefit.

“The substantial price reduction for ‘Starter Packages’ will allow first-time patients to try our medications at an extremely affordable price-point,” said Dr. Stephen Dahmer, Chief Medical Officer of Vireo Health. “This will significantly reduce the financial burden facing new patients trying to determine if medical cannabis could provide them with therapeutic benefits and improve their quality of life.”

These price reductions come on top of MinnMed’s existing compassionate discount program for low-income patients which provides those eligible for Medical Assistance, Minnesota’s Medicaid program, with an additional 15-percent discount. Moreover, under a newly added discount program, patients that are active-duty military or veterans will also be eligible for a 15-percent discount.

Detailed information about MinnMed products and new prices can be found online at https://minnesotamedicalsolutions.com/products/. The new prices are effective immediately.

###

 

 

vireo-minnmed-price-reductions

Detailed information about MinnMed products and prices can be found online at https://minnesotamedicalsolutions.com/products/. The new prices are effective immediately.

MinnMed to Contribute 5% of Annual Profits to Community Programs

Medical Cannabis Company Announces Annual Grant to the City of Otsego

Minneapolis, MN – As 2016 comes to a close, Minnesota Medical Solutions (“MinnMed”), one of the two companies licensed by the state to cultivate, manufacture and dispense medical cannabis, will be awarding a $20,000 grant to the City of Otsego.

As part of its annual commitment to the city in which it operates its state-of-the-art cultivation and manufacturing facility, MinnMed will award a $20,000 unrestricted grant to the City of Otsego which may be used to support local investments in public safety, parks and streets. Going forward, MinnMed will allocate 2% of its annual net profits to the City of Otsego.

“Supporting local communities is a core value of our company,” said Dr. Kyle Kingsley, Chief Executive Officer of Minnesota Medical Solutions and Vireo Health. “We couldn’t be happier with our decision to build our business in Otsego, a business-friendly city, with a high caliber workforce. As MinnMed becomes more profitable, we look forward to contributing even more to the local community that has embraced us and supported our growth.”

-30-

About Minnesota Medical Solutions
Minnesota Medical Solutions is a physician-led company dedicated to providing best-in-class cannabis-based medications and top quality patient care. The company provides a wide array of scientifically formulated, third-party tested cannabis-based products derived from the highest quality plants and utilizes its separation chemistry capabilities to create products with novel cannabinoid combinations. Minnesota Medical Solutions is a wholly owned subsidiary of Vireo Health, LLC. For more information, visit http:/www.minnesotamedicalsolutions.com.

Star Tribune: PTSD is added to Minnesota’s medical pot program

Post-traumatic stress disorder, or PTSD, is being added to the list of conditions covered by Minnesota’s medical cannabis program, effective next August.

The expansion, announced Thursday by Health Commissioner Dr. Ed Ehlinger, adds an option for the estimated 8 percent of Minnesotans who, at some point in their lives, will suffer PTSD, a condition that can cause people to relive the emotion of traumatic experiences through panic attacks, nightmares and severe anxiety.

Minnesotans also petitioned to add arthritis, depression and six other conditions, but Ehlinger said the research to date didn’t support the others as strongly.

“PTSD presented the strongest case for potential benefits and a relative lack of good treatment alternatives,” said Ehlinger, who has discretion under state law to enlarge program coverage.

The medical cannabis program already covers seizure disorders, glaucoma, HIV/AIDS, Tourette’s syndrome and intractable pain — which was added earlier this year and resulted in a surge of patients.

Roughly 3,500 Minnesotans with qualifying conditions are certified to receive medical cannabis, which for now is provided only in oil or pill form in the state. Ehlinger also said Thursday that the state will permit the use of medical cannabis in a topical form, such as patches or creams, starting next year.

Read more here.

MPR News: Minnesota OKs medical pot for post-traumatic stress disorder

b9ae4b-20150626-medical-cannabis-2

Minnesota will allow the use of medical marijuana to treat people suffering post-traumatic stress disorder, state health officials said Thursday.

The Minnesota Department of Health had been weighing requests to expand the use of medical cannabis for PTSD, autism, arthritis, depression and other conditions.

“While the process of reviewing these potential additions was difficult due to the relative lack of published scientific evidence, PTSD presented the strongest case for potential benefits,” Health Commissioner Dr. Ed Ehlinger said in a statement.

“PTSD also has few effective treatment alternatives available for some patients with the condition,” he added.

Currently, 16 states list PTSD as a qualifying condition for medical marijuana, according to the National Conference of State Legislatures, and three others, plus Washington, D.C., give doctors “broad latitude” to recommend it for any serious conditions.

Read more here.

Star Tribune: Half of medical pot dispensed in Minnesota is prescribed to ease pain

screen-shot-2016-11-30-at-2-07-53-pm

By JENNIFER BROOKS , STAR TRIBUNE
November 08, 2016 – 5:01 PM
When Minnesota’s medical marijuana program opened its doors to pain patients this summer, the hope was that people in pain, and a program struggling with growing pains, might be able to help each other.

That was three months ago. Since then, pain patients have rushed to a program that has battled sluggish enrollment and high prices since its launch last year. Half the people currently enrolled are pain patients, and while it’s too soon to know if that’s enough to save Minnesota’s cannabis program, many patients say the program has already saved them.

“It’s given me my life back,” said Jeanne Luck, one of the 1,667 Minnesotans who have turned to the Office of Medical Cannabis in search of relief from intractable pain — severe, chronic pain that is not eased by the usual painkillers, opioids or therapy.

Learn more about Jeanne’s powerful story and experience with Minnesota Medical Solutions here.

KSTP: Minnesota Medical Marijuana Manufacturer Optimistic Prices Could Drop Soon

screen-shot-2016-12-06-at-10-43-57-am

It’s been three months since chronic pain became a qualifying condition for medical marijuana in Minnesota. While the program continues to struggle with low enrollment and high costs, some see reasons for optimism.

One such reason is a recent uptick in patients. According to the most recent numbers from the state, more than 700 health care practitioners are now authorized to certify patients for the state’s medical marijuana program, and nearly 4,000 Minnesotans are now enrolled.

“Going from 18 medications to three medications, and my cannabis has been the best thing that has ever happened to me,” Jody Taylor-Haye said Tuesday morning.

She’s one of many chronic pain patients who say the last three months have been life-changing.

But the program is far from perfect.

“We’re competing with Percocet, where you can basically buy a bottle of 60 or 90 Percocet that can kill most people, and you can get that for a $6 copay,” explained Minnesota Medical Solutions CEO Dr. Kyle Kingsley. “So it’s really hard to compete with that.”

Minnesota Medical Solutions is one of two medical marijuana manufacturers in Minnesota. Since chronic pain became a qualifying condition, Kingsley said they’ve gained about 1,000 new patients, calling it “an objectively good thing.”

Watch the KSTP clip in its entirety here.

 

NEW PRODUCT HELPS PATIENTS MODERATE MEDICAL CANNABIS SIDE EFFECTS

NEW PRODUCT HELPS PATIENTS MODERATE MEDICAL CANNABIS SIDE EFFECTS

Special Vaporizer Cartridge Helps Patients Only Get As Much THC As Needed

Minneapolis, MN (August 31, 2016) – Minnesota Medical Solutions (MinnMed) today announced that it had developed a new product that will help patients moderate the delivery of THC, the primary psychoactive chemical found in the cannabis plant that can cause side effects, such as sensory distortion and lowered reaction time.

The Company’s new “MinnMed Silver” product is a prefilled vaporizer cartridge containing a formulation of natural ingredients and a small amount of THC (tetrahydrocannabinol), one of the two primary medicinal chemicals in cannabis. This special formula was created to minimize the various THC-related side effects experienced by many patients. It is the only product of its type available to Minnesota patients.

“Seniors and other patients are understandably wary of side effects,” said Kyle Kingsley, M.D., Chief Executive Officer of MinnMed and its parent company Vireo Health. “While the side effects associated with cannabis are much milder than patients have with opioid pain killers, our new MinnMed Silver formulation will help patients go slow and only get as much medicine as they need.”

For patients that don’t need THC for effective treatment, such as patients with conditions involving seizures, the THC-free MinnMed Violet formulation can be used. However for other patients, such as pain patients, THC is necessary to provide relief. For pain patients, the MinnMed Silver formulation can ensure that patients without experience with cannabis don’t get more THC than then they need.

MinnMed Silver is being released at a time when many new patients suffering from pain are trying medical cannabis, often as an alternative to opioid-based medications. As of August 1, 2016, Minnesota patients with pain that can’t be relieved using conventional treatment methods are eligible to purchase medical cannabis.

The heaviest users of opioids are seniors, according to a December 2014 Express Scripts report. At the same time, they are the age group with the least experience with cannabis, according to a July 2015 Gallup survey. To date, Minnesota seniors, age 65 and above, have been underrepresented in the State’s medical cannabis program. While seniors represent 18 percent of the State’s adult population, ages 18 and above, they only account for 12 percent of the active adult patients in the State’s medical cannabis program.

“As an emergency medicine physician, I saw that many seniors were opioid victims,” said Kingsley. “With seniors disproportionately suffering from pain and suffering opioid-related tragedies, we need to help them overcome their cannabis-related concerns.”

In April, MinnMed released the FREDOM (Flexible Reduction and Expedited Discontinuation of Opioid Medications) protocol as a potential tool for physicians to help patients struggling with chronic or intractable pain replace opioids with medical cannabis.

“Dosing by milligram is one of the most important differentiators of a medical approach to cannabis-based medicines. Observing patients who respond to very low dosing, yet are cautious or sensitive to the psychotropic effects of THC, inspired the development of MinnMed Silver,” said Stephen Dahmer, M.D., Chief Medical Officer of Vireo Health of New York. “This product is aligned with our ‘Start Low. Go Slow.’ protocol by providing patients with a medical cannabis product containing much lower levels of THC. While MinnMed Silver could be used by patients of all ages, the impetus for this new offering has been informed by interactions with senior patients in our Cannabis Patient Centers.”

MinnMed has four Cannabis Patient Centers located in Bloomington, Minneapolis, Moorhead and Rochester.

– END –

Contact: Joe Loveland, joe@lovelandcommunications.com, 651-248-8534